Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens

Cellular immunotherapy is a promising new therapeutic approach for hepatocellular carcinoma (HCC), which has a high recurrence rate, irrespective of the treatment administered. In this study, we attempted to improve the cytolytic activity of effector T-lymphocytes against HCC. T-lymphocytes were act...

Descripción completa

Detalles Bibliográficos
Autores principales: Chieochansin, Thaweesak, Thepmalee, Chutamas, Grainok, Janya, Junking, Mutita, Yenchitsomanus, Pa-thai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881468/
https://www.ncbi.nlm.nih.gov/pubmed/31776459
http://dx.doi.org/10.1038/s41598-019-54087-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881468/
https://www.ncbi.nlm.nih.gov/pubmed/31776459
http://dx.doi.org/10.1038/s41598-019-54087-0

Ejemplares similares